(Total Views: 153)
Posted On: 03/31/2022 10:11:08 AM
Post# of 44029

$AVCO is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies. https://finance.yahoo.com/news/avalon-globoca...21173.html

